Jeannie was appointed as an Independent Non-Executive Director and designated a Scientific & Medical Expert on 4 March 2024.
Jeannie is a pioneer in the field of RNA Biology and its application to drug development and therapeutics. In addition to senior leadership positions held at both Harvard Medical School and the Massachusetts General Hospital, Jeannie co-founded Translate Bio and Fulcrum Therapeutics, two biotech companies specialising in RNA and epigenetic therapies.
Jeannie is a Member of the National Academy of Sciences, the National Academy of Medicine, a Harrington Rare Disease Scholar of the Harrington Discovery Institute, a recipient of the Lurie Prize from the Foundation for the National Institutes of Health, an awardee of the Centennial Prize from the Genetics Society of America, the 2010 Molecular Biology Prize and the 2020 Cozzarelli Prize from the National Academy of Sciences, U.S.A, and a Fellow of the American Association for the Advancement of Science. She has also served on the Board of the Genetics Society of America.
External appointments:
- Endowed Chair in Molecular Biology and Professor of Genetics (and Pathology), Harvard Medical School
- Acting Chair of the Department of Molecular Biology, Massachusetts General Hospital
- Member of Scientific Advisory Board, Skyhawk Therapeutics, Inc.
- Founder of and advisor to Fulcrum Therapeutics, Inc.
